ロード中...
The evolution of alternative splicing in glioblastoma under therapy
BACKGROUND: Alternative splicing is a rich source of tumor-specific neoantigen targets for immunotherapy. This holds promise for glioblastomas (GBMs), the most common primary tumors of the adult brain, which are resistant to standard-of-care therapy. Although most clinical trials enroll patients at...
保存先:
| 出版年: | Genome Biol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7835670/ https://ncbi.nlm.nih.gov/pubmed/33499924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13059-021-02259-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|